EQT X, through its indirectly owned subsidiary Oak BidCo S.à r.l., has secured an ownership of 72.5% of the votes in OEM International Aktiebolag (publ) and has announced a public cash offer to all shareholders. The shares of OEM International are admitted to trading on Nasdaq Stockholm, Mid Cap. The total value of the offer is approximately SEK 15.2 billion.

OEM International is one of Europe's leading technology trading companies with 34 operating units in 15 countries. The group operates in the trade of components and systems from leading suppliers in selected markets in Europe. A well-structured local market organisation and efficient logistics make OEM a better alternative to the supplier’s own sales organisations.

Vinge’s team mainly consists of Sofie Bjärtun, Erik Sjöman, Joel Magnusson, Maximilian Bengtsson and Lovisa Jonassen (Capital Markets and Public M&A), Christina Kokko and Eléonore Friberg (M&A), Sebastian Örndahl, Noelia Martinez, Julia Rydin and Martin Hammarskiöld (Regulatory), Josefine Lanker (Banking and Finance), Christoffer Nordin and Elis Allmark (Commercial Agreements), Niclas Winnberg (Real Estate), Ebba Svenburg (Employment), Arvid Axelryd (Intellectual Property), Eva Fredriksson (IT), Hayaat Ibrahim (Compliance), Nicklas Thorgerzon (GDPR) and Julia Ulander Kull (Transaction Support Coordinator).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025